BioSkryb Genomics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
55
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$20M
- Investors
-
3
BioSkryb Genomics General Information
Description
Developer of a genome amplification system designed to utilize cellular heterogeneity. The company transforming through its single-cell whole genome and whole transcriptome amplification tools, scientists and clinicians can gain an unprecedented view of the genome, transcriptome and proteome within a single cell to understand the drivers, mechanisms and management of complex diseases and transform single-cell molecular discovery and analysis, enabling medical researchers and clinicians to elucidate the mechanisms of pathology in the genome.
Contact Information
Website
www.bioskryb.comCorporate Office
- 2810 Meridian Parkway
- Suite 110
- Durham, NC 27713
- United States
Corporate Office
- 2810 Meridian Parkway
- Suite 110
- Durham, NC 27713
- United States
BioSkryb Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 01-May-2025 | $20M | Completed | Generating Revenue | ||
| 1. Seed Round | 17-May-2019 | Completed | Generating Revenue |
BioSkryb Genomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 2 | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
BioSkryb Genomics Comparisons
Industry
Financing
Details
BioSkryb Genomics Competitors (6)
One of BioSkryb Genomics’s 6 competitors is Oxford Nanopore Technologies, a Formerly VC-backed company based in Oxford, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Oxford Nanopore Technologies | Formerly VC-backed | Oxford, United Kingdom | ||||
| Watchmaker Genomics | Venture Capital-Backed | Boulder, CO | ||||
| New England Biolabs | Corporation | Ipswich, MA | ||||
| Pacific BioSciences of California | Formerly VC-backed | Menlo Park, CA | ||||
| CD Genomics | Corporation | Shirley, NY |
BioSkryb Genomics Patents
BioSkryb Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025085821-A1 | Methods, systems, and compositions for cell storage and analysis | Inactive | 19-Oct-2023 | ||
| EP-4784791-A1 | Methods, systems, and compositions for cfdna analysis | Pending | 26-Sep-2023 | ||
| WO-2025072326-A1 | Methods, systems, and compositions for cfdna analysis | Inactive | 26-Sep-2023 | ||
| EP-4655437-A2 | Fine needle aspiration methods | Pending | 23-Jan-2023 | ||
| US-20260218168-A1 | Fine needle aspiration methods | Pending | 23-Jan-2023 | C12N15/1096 |
BioSkryb Genomics Signals
BioSkryb Genomics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Seed Healthcare | Venture Capital | Minority | ||
| Anzu Partners | Venture Capital | Minority | ||
| Wilson Sonsini Goodrich & Rosati | VC-Backed Company | Minority |
BioSkryb Genomics FAQs
-
When was BioSkryb Genomics founded?
BioSkryb Genomics was founded in 2018.
-
Where is BioSkryb Genomics headquartered?
BioSkryb Genomics is headquartered in Durham, NC.
-
What is the size of BioSkryb Genomics?
BioSkryb Genomics has 55 total employees.
-
What industry is BioSkryb Genomics in?
BioSkryb Genomics’s primary industry is Biotechnology.
-
Is BioSkryb Genomics a private or public company?
BioSkryb Genomics is a Private company.
-
What is BioSkryb Genomics’s current revenue?
The current revenue for BioSkryb Genomics is .
-
How much funding has BioSkryb Genomics raised over time?
BioSkryb Genomics has raised $31.5M.
-
Who are BioSkryb Genomics’s investors?
Seed Healthcare, Anzu Partners, and Wilson Sonsini Goodrich & Rosati have invested in BioSkryb Genomics.
-
Who are BioSkryb Genomics’s competitors?
Oxford Nanopore Technologies, Watchmaker Genomics, New England Biolabs, Pacific BioSciences of California, and CD Genomics are some of the 6 competitors of BioSkryb Genomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process